Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2012-04-30 | Abraham E. Cohen, 75, joined the Board of Directors during July 2009. Mr. Cohen is an independent international business consultant and is Chairman and President of Kramex Company, a privately owned consulting firm. ... The members of the Audit Committee are Arnold I. Burns, Abraham E. Cohen, and Pedro Lichtinger. ... The members of the Nominating and Corporate Governance Committee are Neal C. Bradsher, Arnold I. Burns, and Abraham E. Cohen. ... The members of the Compensation Committee are Arnold I. Burns, Abraham E. Cohen, and Pedro Lichtinger. ... Abraham E. Cohen received total compensation of $125,219 in 2011. |
| Filing Date | Source Excerpt |
|---|---|
| 2011-04-22 | The Board believes that Mr. Cohens business experience, including his experience as an executive officer of Merck, and his service on other public company boards, combined with his business acumen and judgment provide our Board with valuable operational expertise and leadership skills. |
| 2012-04-06 | Mr. Cohen served as Senior Vice President of Merck & Co. until his retirement in January 1992 and as President of the Merck Sharp & Dohme International Division from 1977 to 1988. Since his retirement, Mr. Cohen has been active as an international business consultant. |
| 2012-11-16 | Abraham E. Cohen is listed as a director, but no software or technical qualifications are described. |
| Filing Date | Source Excerpt |
|---|---|
| 2001-09-10 | Abraham E. Cohen (65) has been Chairman of the Board since June 1994 and a director since June 1993. ... (5) Ex-officio member of all committees, except the Science and Technology Committee |
| 2002-11-13 | Abraham E. Cohen (66) has been Chairman of the Board since June 1994 and a director since June 1993. He is ex-officio member of all committees. |
| 2003-09-23 | Abraham E. Cohen (67) has been our Chairman of the Board since June 1994 and a director since June 1993 ... (5) Ex-officio member of all committees |
| 2004-09-27 | Abraham E. Cohen (68) has been our Chairman of the Board since June 1994 and a director since June 1993, and is presently an independent consultant. |
| 2009-08-21 | Abraham E. Cohen has been our Chairman of the Board since June 1994 and is presently an independent consultant. ... Mr. Cohen is a director of the following public companies: Akzo Nobel Nv., Chugai Pharmaceutical Co., Ltd., Neurobiological Technologies, Inc. and Teva Pharmaceutical Industries, Ltd. ... Non-employee directors received a fee of $1,500 for each Board of Directors and Committee meetings attended and $2,500 for each Audit Committee meeting attended, payable at each director's option in cash or common stock. Directors also receive annually $15,000 of common stock valued at the fair market value of the common stock on the date of grant for serving as a board member during the fiscal year. ... Director Compensation table shows Abraham E. Cohen total compensation as $22,500. |
Data sourced from SEC filings. Last updated: 2025-12-06